Elevated baseline LDH levels predict worse clinical outcomes in heart failure with reduced ejection fraction and modestly ...

The device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.

Study links exosomal microRNA to ventricular remodelling in heart failure. Discover how this biomarker could inform future ...

AHA scientific statement provides a framework for standardizing baseline and provocative invasive hemodynamic protocols in HF ...

Investing.com -- CVRx Inc. (NASDAQ:CVRX) stock rose 2.9% in after-hours trading Thursday following the company’s announcement ...

Background Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and management across the full HF spectrum remain incompletely characterised. Methods ...

Cardiovascular disease that presents first as heart failure is common in type 2 diabetes and its risk factors differ from those of cardiovascular disease that present first as atherosclerotic events.

Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is ...

With COVID now out of the top 5, stroke has taken over the number 4 position thanks to rising death rates in young and old.

CVRx, Inc. a developer of neuromodulation solutions for patients with cardiovascular diseases, announced initiation of the ...

A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and ...

Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and ...